InvestorsHub Logo
Followers 253
Posts 17922
Boards Moderated 0
Alias Born 01/19/2006

Re: north40000 post# 277126

Tuesday, 10/25/2016 8:16:58 AM

Tuesday, October 25, 2016 8:16:58 AM

Post# of 345789
About 7 p.m. yesterday, Dew posted on the BTValue board that MRK had a strong case for NCCN endorsement or acceptance of its request in the situation reported in the article I reported yesterday.

One of the 3 trials that NCCN selected for trial also involves Keytruda with Bavi for treatment of certain disease state. How about both companies asking NCCN to conduct trials of that combination therapy in yet other disease conditions. Funding to be provided. Same or related clinical investigator at same or different NCCN facility(out of the 26) to be involved. Instant communication back and forth.

Is the above how the clinical trial process will evolve? Just a thought.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News